SCHEMBL13194906

SCHEMBL13194906

CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4cnn(C5CCN(C(=O)OC(C)(C)C)CC5)c4)cc23)c1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 12/20 0.57
BRAF P15056 3/20 0.57
RIPK2 O43353 2/20 0.57
RAF1 P04049 2/20 0.57
KDR P35968 2/20 0.57
MAP2K2 P36507 2/20 0.57
TGFBR2 P37173 2/20 0.57
NEK2 P51955 2/20 0.57
MAP2K1 Q02750 2/20 0.57
TNK2 Q07912 2/20 0.57
MAP2K5 Q13163 2/20 0.57
PTK6 Q13882 2/20 0.57
NEK11 Q8NG66 2/20 0.57
MAP3K20 Q9NYL2 2/20 0.57
MAP4K5 Q9Y4K4 2/20 0.57
ABCB11 O95342 1/20 0.57
EGFR P00533 1/20 0.57
KRAS P01116 1/20 0.57
PGR P06401 1/20 0.57
RET P07949 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2016012 0.94 CYP2C19 (0.64) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL12988611 0.90 CYP2C19 (0.63) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL12988318 0.89 CYP2C19 (0.62) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL12988665 0.89 BRAF (0.63) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL12467668 0.85 CYP2C19 (0.69) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL297780 0.84 BRAF (0.70) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL12989354 0.83 CYP2C19 (0.72) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL12988744 0.83 CYP2C19 (0.71) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL2013819 0.83 CYP2C19 (0.70) CYP2C19BRAFRIPK2RAF1KDR
SCHEMBL2018833 0.82 CYP2C19 (0.53) CYP2C19BRAFCYP2C9CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012138809-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ZHANG DAWEI (US) 2012-10-11 WO disclosed